Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juan Pablo Arab

Showing results (1-10 of 257) with videos related to

Pageof 26
Sort By:
Nature Reviews. Gastroenterology & Hepatology|December 6, 2022
Advancing alcohol-related liver disease: from novel biomarkers to refining selection for liver transplantationJuan Pablo Arab, Ramon Bataller
Hepatology (Baltimore, Md.)|July 18, 2025
Decoding liver risk: A deep dive into the Baveno VII "Rule-of-Five" criteriaKaanthi Rama, Juan Pablo Arab
Hepatology (Baltimore, Md.)|March 18, 2026
When quantity isn't quality: Microbiota-driven humoral dysfunction in severe alcohol-associated liver diseaseButros Fakhoury, Juan Pablo Arab
Hepatology (Baltimore, Md.)|November 14, 2025
A bright future: Sustainable treatment of gastric varicesResham Ramkissoon, Juan Pablo Arab
Hepatology (Baltimore, Md.)|March 17, 2025
AKI Alert: Anakinra + Zinc, and the Renal RollercoasterVinay Jahagirdar, Juan Pablo Arab
Hepatology (Baltimore, Md.)|December 16, 2024
Unraveling bile acid dynamics in severe obesityFrancisco Idalsoaga, Juan Pablo Arab
Hepatology (Baltimore, Md.)|February 18, 2026
Rethinking liver transplant allocation: Balancing urgency and utilityPrabhat Kumar, Juan Pablo Arab
Hepatology (Baltimore, Md.)|April 17, 2026
Beyond clinical comorbidities: Social determinants of health shape cirrhosis riskHyundam Gu, Juan Pablo Arab
Hepatology (Baltimore, Md.)|February 17, 2025
Revealing new biomarker to predict MASLD progressionGowthami Kanagalingam, Juan Pablo Arab
Hepatology (Baltimore, Md.)|December 16, 2025
The roadMAP of how terlipressin reverses HRS-AKIMichael Eiswerth, Juan Pablo Arab
Pageof 26

Showing results (1-10 of 257) with videos related to

Sort By:
Pageof 26
Nature Reviews. Gastroenterology & Hepatology|December 6, 2022
Advancing alcohol-related liver disease: from novel biomarkers to refining selection for liver transplantationJuan Pablo Arab, Ramon Bataller
Hepatology (Baltimore, Md.)|July 18, 2025
Decoding liver risk: A deep dive into the Baveno VII "Rule-of-Five" criteriaKaanthi Rama, Juan Pablo Arab
Hepatology (Baltimore, Md.)|March 18, 2026
When quantity isn't quality: Microbiota-driven humoral dysfunction in severe alcohol-associated liver diseaseButros Fakhoury, Juan Pablo Arab
Hepatology (Baltimore, Md.)|November 14, 2025
A bright future: Sustainable treatment of gastric varicesResham Ramkissoon, Juan Pablo Arab
Hepatology (Baltimore, Md.)|March 17, 2025
AKI Alert: Anakinra + Zinc, and the Renal RollercoasterVinay Jahagirdar, Juan Pablo Arab
Hepatology (Baltimore, Md.)|December 16, 2024
Unraveling bile acid dynamics in severe obesityFrancisco Idalsoaga, Juan Pablo Arab
Hepatology (Baltimore, Md.)|February 18, 2026
Rethinking liver transplant allocation: Balancing urgency and utilityPrabhat Kumar, Juan Pablo Arab
Hepatology (Baltimore, Md.)|April 17, 2026
Beyond clinical comorbidities: Social determinants of health shape cirrhosis riskHyundam Gu, Juan Pablo Arab
Hepatology (Baltimore, Md.)|February 17, 2025
Revealing new biomarker to predict MASLD progressionGowthami Kanagalingam, Juan Pablo Arab
Hepatology (Baltimore, Md.)|December 16, 2025
The roadMAP of how terlipressin reverses HRS-AKIMichael Eiswerth, Juan Pablo Arab
Pageof 26